Healthcare · Consumer · One spine
A commercial decision is only as good as the evidence under it — whether the brief is a named brand versus a competitor in hospital accounts, or a pack versus a rival on a traditional-trade shelf. Evidence is only trustworthy if you can see how it was made. This page is that look behind the curtain: how BioNixus designs each study, recruits and verifies the right respondents, governs fieldwork, validates the data, meets the ethics bar in every market, and reports findings a marketing or access team can act on. One governance spine. Two theatres: healthcare and consumer.
Localized methodology mirrors: English · Deutsch · Français · Español · Português · Русский · 中文 · العربية. Align evidence plans with the market research insights hub at market research data insights hub or explore GfK alternative coverage in Egypt.
One spine
BioNixus is a primary market research firm. The same six controls — design, sampling, fieldwork, validation, ethics, and reporting — run on a healthcare market research brief and on a consumer or industry brief. What changes is who sits in the sample, which code governs the honorarium, and how fine the tables must be cut.
| Control | Healthcare | Consumer & other industries |
|---|---|---|
| Who we talk to | Physicians, payers, KOLs, hospital and pharmacy accounts | Shoppers, category buyers, retailers, distributors, traditional trade |
| How we find them | Licence registers, hospital networks, specialty societies | Named accounts, trade lists, intercepts, mystery shops, consented re-contact |
| Codes that bind the work | BHBIA, EphMRA, pharmacovigilance, fair-market-value honoraria | ESOMAR, local consumer-research codes, auditable incentives |
| What the pack must survive | Medical, access, and HTA diligence | Brand, trade, and commercial-director scrutiny |
01
Every programme starts by turning a business question into something a study can actually answer. We sit down with the people who will use the evidence — brand, medical, and market access on a healthcare brief; brand, category, and trade on a consumer brief — and pin objectives specific enough to drive a decision, yet flexible enough to course-correct when early data points somewhere unexpected. A study designed around the wrong question is fast, cheap, and useless.
Structured questionnaires, validated scales, and conjoint or MaxDiff where trade-offs matter — physician treatment choice or shopper pack choice. Instruments get a cognitive pre-test with at least five respondents. Skip-logic, randomisation, and trap questions protect integrity. Quantitative research.
Semi-structured guides built around decision-tree logic. Healthcare: physician interviews, payer boards, hospital ethnography. Consumer: shopper depths, retailer and distributor interviews, in-store observation. Guides are piloted and refined after the first two to three sessions. Qualitative research.
Used when the brief needs both statistical grain and explanatory depth — a launch study that pairs a 200-physician survey with specialist depths, or a category study that pairs a shopper survey with named-account visits the syndicated feed cannot show.
02
Sample quality determines the credibility of any insight. Healthcare samples come from proprietary professional panels across 17+ EMEA and GCC markets, plus accredited partners who meet ESOMAR and BHBIA sourcing standards. Consumer and industry samples are built around the accounts and channels in the brief — not an open-internet opt-in pool.
Healthcare
Licensing authority verification. Recruitment from regulatory databases — DHA Dubai, DOH Abu Dhabi, SFDA Saudi Arabia, MOHAP UAE, and MOH Kuwait — so each panellist has an auditable licence, specialty, and practice setting before first contact.
Hospital and clinic networks. Specialist referral through medical education and clinic coordinators at major facilities, including SEHA, Mediclinic, Aster, NMC, Cleveland Clinic Abu Dhabi, and Saudi German Hospital networks — for therapy-area depth registers alone do not surface.
Professional associations. Society rosters are cross-referenced with licensing registers so membership lists never stand alone.
Three-layer validation. Licence check, specialty confirmation, and practice-setting validation. Quarterly refresh removes relocated or retired physicians.
Consumer & industry
Named accounts. Retailers, distributors, independent pharmacies, grocers, and bakals are sampled when that is where volume moves — the grain syndicated Nielsen and GfK-style feeds typically miss. See account-level market research.
Shopper and buyer quotas. Category buyers and household shoppers are recruited to the SKU, channel, and city in the brief — not a national average that hides the account.
Mystery shop and intercept. Used when the question is what happens at the shelf, the counter, or the traditional-trade store — methods a panel dashboard cannot substitute.
Consented re-contact. Verified respondents from previous waves who agreed to future contact remain the fastest route when timeline is the priority — in both theatres.
Sample sizes are calculated against predefined statistical power targets. For most quantitative programmes, we target a minimum of ±5% margin of error at the 95% confidence level within each reportable sub-group. Where the population is inherently small — rare-disease specialists, national formulary members, or a short list of key-account buyers — we apply census-style recruitment and adjust analysis to the smaller base. Quota controls enforce representation by role, setting, volume, and geography so no single country dominates a multi-market file.
03
Fieldwork is where methodology meets operational discipline. Every project — healthcare or consumer — runs against a protocol that specifies recruitment timelines, respondent honorarium rates (compliant with the relevant industry code), interview scheduling windows, and escalation procedures for quota shortfalls.
Quantitative surveys include real-time dashboards for completion rates, median time, drop-off, and straight-lining. Surveys that consistently finish in less than one-third of the expected median time are flagged and excluded if quality checks fail.
Qualitative fieldwork is recorded with consent and transcribed verbatim. Moderators submit debrief notes within 24 hours. Multi-market studies have a central project manager and daily stand-ups with local teams to catch translation discrepancies or recruitment drift — whether the respondent is a consultant in an NHS trust or a category buyer in Cairo.
Healthcare clinical trial support fieldwork follows the same spine, with extra controls for site identification and investigator profiling. Consumer mystery-shop and account-visit waves follow the same spine, with extra controls for store selection and SKU availability logs.
04
Raw data undergoes a multi-stage validation pipeline before analysis. The first stage is automated: algorithms flag duplicate IDs, impossible combinations (a GP claiming to perform neurosurgery — or a shopper claiming a channel they cannot reach), and statistically anomalous answer patterns.
The second stage is analyst-led. A senior researcher reviews flagged records against recruitment data and, where necessary, contacts respondents. Records that cannot be validated are removed with a documented exclusion rationale.
AI-augmented quality assurance adds a third layer. Natural-language models evaluate open-ends for coherence, relevance, and minimum length. Qualitative transcripts go through topic-modelling to surface latent themes a first human pass might miss. Machine-generated themes are then validated by the analysis team — AI accelerates pattern detection; every interpretive conclusion is human-reviewed.
Clients receive datasets they can trust for internal decisions and, on healthcare briefs, for regulatory or HTA submissions. See how evidence feeds market access and HTA strategy — and how consumer briefs feed brand and trade decisions instead.
05
Every BioNixus project operates under GDPR, the UK Data Protection Act, ESOMAR guidelines, and local data-protection law — including Saudi PDPL, the UAE Federal Data Protection Law, and Kuwait CITRA requirements. That floor applies to healthcare and consumer work alike.
Healthcare programmes add BHBIA Legal & Ethical Guidelines and the EphMRA Code of Conduct. Studies that touch patient data — even indirectly through physician-reported records — obtain ethical review where required and apply extra de-identification. Adverse-event reporting is briefed to every moderator before fieldwork, with a 24-hour escalation to the client's pharmacovigilance team.
Consumer and industry programmes stay inside ESOMAR and the applicable local consumer-research code. Incentives are processed through auditable channels. Healthcare honoraria are additionally benchmarked against fair-market-value guidelines issued by local pharmaceutical industry bodies — protecting the respondent and the sponsor from transparency and anti-bribery risk.
Consent is obtained before collection, in the respondent's preferred language, with use and retention explained. Personal data is pseudonymised and stored on encrypted EU-based servers. Identifiable information is never shared with clients unless the respondent gives explicit extra consent for follow-up.
06
Insight has no value until it reaches the people who act on it. Reports open with the three to five headline findings and the recommended actions — before the reader hits supporting data. That is true for a Head of Marketing on a consumer brand and for a market-access lead on a therapy launch.
Quantitative reports include methodology appendices — sample composition, weighting, confidence intervals, and the questionnaire — so the evidence can be evaluated on its own terms. Qualitative reports present thematic analysis with anonymised verbatim.
Standard deliverables include interactive dashboards for trackers, executive slide decks for board-level presentations, and technical appendices. Healthcare packs can be cut for HTA or regulatory dossier teams. Consumer packs are cut for brand, trade, and SKU decisions. For competitive intelligence programmes, we provide monitoring reports with alert-driven updates in either theatre.
All reports undergo a two-stage internal review — analyst for data accuracy, senior director for strategic coherence — before delivery. KOL and stakeholder mapping follows the same protocol, with extra visualisation for influence networks.
Yes — the governance spine is the same: decision-first design, verified sampling, fieldwork protocols, multi-stage validation, ethics, and a report built for the people who act. The respondents, codes, and deliverable grain change. Healthcare briefs recruit physicians, payers, and hospital accounts under BHBIA, EphMRA, and pharmacovigilance rules. Consumer briefs recruit shoppers, category buyers, and named retail accounts under ESOMAR and local consumer-research codes.
Healthcare panellists pass licence verification against authority registers, specialty confirmation, and practice-setting checks through facility directories. We recruit from verified physician databases, hospital registries, and specialty society lists — not open-internet opt-in pools. Quarterly refresh cycles remove relocated or retired physicians.
Consumer samples are built around the accounts and channels where volume actually moves — modern trade, independent pharmacies and grocers, bakals, and named distributors — plus shopper and category-buyer quotas where the brief needs household or basket evidence. Screeners are reviewed before fieldwork. Mystery shops, account visits, and intercepts are used when a syndicated panel undersamples the channel.
Every project runs against a protocol for recruitment timelines, compliant honoraria, scheduling windows, and quota-shortfall escalation. Quantitative surveys are monitored in real time for completion time, drop-off, and straight-lining. Qualitative sessions are recorded with consent, transcribed, and debriefed within 24 hours. Multi-market studies have daily stand-ups to catch translation or recruitment drift.
Projects operate under GDPR, the UK Data Protection Act, ESOMAR guidelines, and local laws including Saudi PDPL, the UAE Federal Data Protection Law, and Kuwait CITRA requirements. Healthcare work also follows BHBIA and EphMRA. Consent is taken before collection, data is pseudonymised, and identifiable information is not shared with clients unless the respondent consents to follow-up.
Every deliverable opens with headline findings and recommended actions, then supporting data. Quantitative packs include sample tables, weighting, confidence intervals, and the questionnaire. Qualitative packs include thematic analysis with anonymised verbatim. Tracker studies can include dashboards. Healthcare dossiers can include HTA-ready appendices; consumer packs include brand and trade cuts a Head of Marketing can take to the commercial director.
A multi-market launch study, a single-country shopper or payer landscape, or an always-on competitive programme — the method flexes to the industry, the complexity, and the regulatory context in front of it. Tell us the decision you need to make and we will design the research that meets your evidence bar.